With the desire to bring a smile and offer a small moment of joy, we are proud to be among those who have joined the solidarity initiative “A caress for Christmas“. PHSE has delivered a backpack with gifts to all children, over 3.600, who had to undergo treatments in Italian Pediatric Hospitals (AOPI) during the Christmas Holidays.
Milan, 21 november 2023
In the report published today on il Sole 24 Ore, we are among the Italy’s Growth Champions 2024. The award is dedicated to the 500 Italian companies that have experienced the highest revenue growth in the three-year period from 2019 to 2022.
“Beyond the podium, entering such a rigorous ranking is a great victory for us. It is a significant public recognition that confirms the high potential of our company, capable of competing increasingly on the international stage.” commented Eddy De Vita, Executive President PHSE.
With an average annual growth of 40,20% PHSE ranks 270°.
Check out the complete list of 500 companies, compiled by il Sole 24 Ore and Statista.
The rankings are available online at the following link:
https://lab24.ilsole24ore.com/leader-crescita/
Here, the link to the online dossier:
https://www.ilsole24ore.com/dossier/20231121_leader_crescita_2024-AFjK9xfB
Download the full report
Milan, 10 july 2023
PHSE, a leading pharmaceutical logistics group, announces that it has completed the acquisition of 80% of Air Plus Srl and Bio Pharma Logistics Srl, Italian companies with a strong specialisation in the temperature-controlled transportation of pharmaceuticals, diagnostic samples and biologicals, especially in the international arena (import and export from Italy). One of the founders, Stefano Cazzulani, will retain 20% of both companies and the management direction of them.
Through this transaction, the PHSE Group, which last year recorded more than €75 million in consolidated revenues, not only strengthens its presence in Italy, but also reinforces its Global Forwarding business unit, dedicated to worldwide shipments of drugs, samples and clinical trials in support of pharmaceutical research.
“We are thrilled to welcome Air plus and Bio Pharma Logistics to our Group with an acquisition that represents a further step in the growth process we have undertaken, not only organically, but also through acquisitions,” said Eddy De Vita, Executive Chairman and major shareholder. This is in fact the fifth extraordinary transaction realised by PHSE since the beginning of 2021.
“We are very satisfied with the Group’s performance, continued De Vita, which has already achieved important milestones in the first half of this year, including the expansion of its international presence to the Spanish market with the opening of the new PHSE Spain subsidiary. “
Madrid, 1 june 2023
We are pleased to announce the appointment of Antonio Lopez to the position of General Manager, PHSE Spain, bringing with him a wealth of healthcare experience.
PHSE Spain will be headquartered in Madrid, with an office in Barcelona also, and represents another important building block in our drive to expand the Group’s geographical presence in support of our customers.
Antonio Lopez will be establishing a new team, and high quality facilities, which we expect to be fully operational by Q4 2023… watch this space!
Milan, 5 june 2023
Headquartered in Lodi and with 29 branches worldwide, the small multinational PHSE, active in pharmaceutical logistics, closed the 2022 financial year with a turnover of EUR 75 million, up 67% on the previous year. PHSE specialises in making life-saving drugs, biotechnology products and advanced therapies accessible to all players in the supply chain, from industry to pharmacist, doctor and patient. “This is an activity where compliance with temperatures, on-time delivery, traceability and monitoring of the product’s route are essential factors,” emphasises Executive President Eddy De Vita. A new hub in Bologna (Italy) will be opened by the summer and a new platform in Campania (Italy) is planned for the end of 2023.
Source: Il Sole 24 Ore, by Marco Sabella
Milan, 16 june 2023
PHSE and Bio Transportes, our Brazilian company part of PHSE Group, are proud to support The World Marrow Donor Association WMDA. A global, important society of registries, cord blood banks, donor centres, collection centres, regulators, researchers, technologists, and industry partners with a shared vision to strive for a world where access to lifesaving cellular therapies for all patients is assured and donor’s rights and safety are protected.
We are also honoured to sponsor for the first year the 13th International Donor Registry Conference & WMDA Global Meeting in #Frankfurt where in these days the PHSE Group team, Sandra Rodrigues and Daniela Brandão from Brazil, are meeting with donor registries from around the world to discuss the vital work of the WMDA and ensure shipments arrive on time and in specification.
Milan, 30 june 2023
The goal is ambitious: to become a global leader in pharmaceutical distribution by developing an increasingly capillary, high-performance and comprehensive network There are two strategic levers to achieve this: digitalisation and sustainability. On this basis, Phse, a small multinational with an all-Italian footprint (its headquarters are in Lodi), is aiming to build its growth also at an international level. The numbers are already significant: 566 employees and 29 branches worldwide, in 2022 it has increased its revenues by 67%. And in 2023 there will be at least two acquisitions in addition to the opening of a new branch in Spain.
Leading the company is Eddy De Vita Executive Chairman of Phse “We are proud to be a cutting-edge Italian company specialized in the transportation of healthcare products worldwide,” he explains. “We operate in Italy with five business units and have 14 wholly-owned distribution platforms managed by our group. The same applies to our employees and vehicles. It’s our unique feature that guarantees a high level of service quality, consistency, and reliability. We like to think of ourselves as a small multinational corporation with advanced in-house quality and IT expertise, specializing and excelling in this industry that invests heavily in innovation. Our goal for 2023 is to achieve a turnover of 100 million euros.”
The Numbers
Specialising in temperature-controlled transport of pharmaceuticals, biotech, clinical trials and biological samples serving the hospital channel, with express delivery times within 24/48 hours throughout Italy and Europe, Phse has grown at an average annual rate of around 45% in recent years.
Booming in 2022, with consolidated revenues of EUR 75 million. This result is mainly due to the performance of the ‘global forwarding’ business unit, which is dedicated to the import/export movement of high value-added drugs to and from all over the world.
This objective was also achieved with the consolidation of all other activities (including the transport of radiopharmaceuticals started in 2021) and the 4 acquisitions made, the most recent in Brazil, which accelerated the Group’s growth internationally.
In more detail, last year alone, the company handled over 625 thousand shipments (temperature 2-8 degrees), equal to over 1.3 million packages; over 228 thousand shipments were made (temperature 15-25 degrees), equal to over 651 thousand packages. The average delivery time was within 24-48 hours for 96% of the shipments.
Investments
In spite of the particularly complex and challenging landscape experienced in 2022, characterised by widespread increases in the prices of raw materials and other inputs, the company has embarked on an investment plan for 2023 to accelerate the strengthening of the supply chain and give a further boost to innovation.
“By the summer we will inaugurate a new Pharma Hub in Bologna. Completely air-conditioned, it will represent a reference pole for last-mile distribution to hospitals, pharmacies and laboratories in Emilia Romagna, as well as making the national distribution process more efficient. Furthermore, by the end of the year, we plan to open another platform in Campania, which will replace the current branch, with a tenfold increase in space,” says De Vita.
The Bologna hub
Equipped with the best technology, the Hub will receive the traffic picked up by the network hubs and sort it for local distribution and for the re-routing along the Adriatic ridge of consignments picked up in Northern Italy for the regions of Marche, Abruzzo, Molise and Puglia. The Bologna Transit Point will thus bring more efficiency to the national distribution process with a reduction of transits on the network and faster delivery times.
The new 15/25°C Hospital Network Service
And that’s not all, because in the strategic design of having an increasingly capillary distribution network, from April 2023 Phse has introduced the new Hospital +15/25°C service, which has entailed the expansion of its fleet with the entry of more than 100 new refrigerated vehicles, of the latest generation with low environmental impact and with transport capacities higher than the current ones. “Connected to the opening of the Bologna branch, we have launched this new service that will allow us to serve more and more hospitals, which for us represent the most significant channel, with optimised transport solutions +2/8°C and +15/25°C,” De Vita emphasises.
Eyes on digital
Phse’s investments will not be limited to physical assets, however: particular attention is being paid to digitisation. ‘”We strongly believe in innovation, which we support with significant investments,’ De Vita emphasises” In this regard, Phse will be the first player in Italy to implement Rfid technology on a national scale. “This is a technology we are betting on with conviction,’ says De Vita. ‘Our goal is to apply the Rfid system on every single parcel. An important challenge, but one that we are convinced we can win”.
The use of RFID technology
In this perspective of capillary control of every single passage that the drug makes through the distribution network, Phse has matured the need to offer its interlocutors, ranging from the pharmaceutical agent to the hospital pharmacy up to the patient, the certainty of passage detection, i.e. the assurance that each individual package is in the correct area and at the correct temperature.
Specifically, the company decided to apply RFID tags to parcels, borrowing what is already happening in the transport and storage of other mercelogical sectors such as retail, and demonstrating that the adoption of this technology is also possible in the healthcare to pharma supply chain. The advantages are obvious: from the capillary tracking of every single parcel, to the speed and precision of controls; passing through the greater sustainability in transport, to the operational advantages in the execution of warehouse and transit operations.
Watchword: sustainability
Digital innovation, but not only. Because Phse’s growth strategy also passes through sustainability activities, with a keen eye on environmental impact. De Vita points out: ‘As a logistics company, we are sensitive to the issue of environmental sustainability: we have been drawing up ESG balance sheets for two years. And the latest generation of vehicles we have recently purchased also guarantee a very strong reduction in CO2.
Upcoming acquisitions
Also increasing Phse’s structure will be acquisition operations on the one hand and the opening of new branches on the other. “We are in the process of closing at least two acquisitions,” says De Vita, “one in Italy, in the global forwarding, special service area, which will be completed in a few weeks. The other acquisitions will take place in the areas of Benelux, Germany, and the United States. In addition, Phse decided to land in Spain last June with the opening of a new branch. “We identified the right managers to start a new company. The first warehouse has been opened in Madrid, but it is not excluded that we will also be present in Barcelona soon. In Spain we already move a lot of shipments on behalf of many of our customers in the country who ask us to collaborate, not only for clinical trial activities but also for distribution in hospitals’.
Source: aboutpharma.com
Chicago, 13 june 2023
We are proud to be attending our first Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting in Chicago on 24th-27th June 2023. If you are currently shipping worldwide or seek a logistics partner you can trust to manage your global shipping needs then PHSE would welcome the opportunity to speak with you. PHSE is a market leader in radiopharmaceutical logistics and recognised for the depth of experience and worldwide network for the transportation of timecritical radiopharmaceuticals for #therapeutic and diagnostic uses.
We look forward to seeing you all there, booth #1024!
Milan, 31 may 2023
Once again this year, PHSE supported AIRC Charity Dinner attended by internationally renowned scientists funded by the foundation.
PHSE has always been close to cancer research by offering effective logistical support at every stage of a clinical trial around the world, making therapies accessible to patients suffering from oncological diseases.
